Niagen Bioscience, Inc.
NAGE
$7.38
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.86% | 12.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.86% | 12.49% | |||
| Cost of Revenue | 17.00% | 3.25% | |||
| Gross Profit | 12.05% | 18.60% | |||
| SG&A Expenses | -26.80% | 5.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.19% | 4.27% | |||
| Operating Income | 343.88% | 725.78% | |||
| Income Before Tax | 298.51% | 12,620.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 282.27% | 12,620.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 282.27% | 12,620.00% | |||
| EBIT | 343.88% | 725.78% | |||
| EBITDA | 304.66% | 3,781.63% | |||
| EPS Basic | 277.73% | 12,450.00% | |||
| Normalized Basic EPS | 294.81% | 15,500.00% | |||
| EPS Diluted | 332.00% | 10,100.00% | |||
| Normalized Diluted EPS | 279.47% | 15,200.00% | |||
| Average Basic Shares Outstanding | 1.28% | 0.55% | |||
| Average Diluted Shares Outstanding | 5.03% | 2.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||